Yellow fever is caused by a virus that is transmitted by mosquitoes. The virus is present in Africa and South America and affects humans and nonhuman primates. Although an individual cannot transmit this infection directly to others, an infected person or nonhuman primate can transmit it to a mosquito when bitten.
Etiology and Pathogenesis of Yellow Fever
Yellow fever virus (YFV) is an enveloped, single-stranded RNA virus in the genus Orthoflavivirus within the family Flaviridae. YFV is zoonotic and has been recognized as a substantial cause of disease in humans for centuries (1, 2, 3).
YFV is currently endemic and intermittently epizootic and epidemic in sub-Saharan Africa and tropical South America (1, 4, 5). There are concerns that YFV could establish itself in Asia and North America, because competent vector species are present in those regions (2).
YFV persists in nature via transmission among nonhuman primates, horizontal transmission via blood-feeding mosquitoes, and transovarial transmission in competent vectors (3). It operates through three cycles: sylvatic, urban, and intermediate (savanna).
During the sylvatic cycle of YFV, the virus is transmitted between nonhuman primates and forest-canopy mosquito species such as Aedes africanus, Haemagogus spp, and Sabethes spp.
During the urban cycle of YFV, the virus is transmitted between humans and peridomestic mosquitoes (Aedes aegypti).
In Africa, the intermediate cycle of YFV features transmission from tree hole–breeding Aedes spp to humans along jungle edges (1, 5).
Clinical Findings of Yellow Fever
Neotropical primates generally experience more severe clinical signs of yellow fever than do African primates, and they have an incubation period of 3–6 days (2). Among neotropical primates, the genus Alouatta (howler monkeys) is considered the most susceptible.
Most neotropical primates with yellow fever are found dead without prior clinical signs. When clinical signs are present, they tend to be nonspecific. Conversely, Asian primates appear not to be susceptible to this disease (4).
Diagnosis of Yellow Fever
Virus isolation, PCR, histological examination, and immunohistochemistry
Infection with YFV can be diagnosed by means of virus isolation, RT-PCR assay, serological testing, histological examination, or immunohistochemistry. Animals that survive the disease develop neutralizing antibodies against YFV.
On serological testing, the presence of IgM in the absence of prior vaccination indicates YFV infection; however, other flaviviruses must be ruled out (2, 4).
Control of Yellow Fever
Surveillance programs in endemic areas
Physical barriers and insect repellents in infected areas
Vaccination for humans in high-risk areas
Effective yellow fever control relies on surveillance and accurate diagnostics to detect outbreaks early and deploy control measures swiftly. Most outbreaks in neotropical primates and humans occur simultaneously, indicating a link between epizootics and epidemics. This connection underscores the importance of surveilling nonhuman primates to detect virus circulation early and to support prompt public health responses (2, 4).
Vaccines against yellow fever are available, and the human 17D vaccine effectively prevents disease in nonhuman primates. However, mitigation strategies continue to rely largely on vector control methods, such as chemical and biological controls, traps, screens, and elimination of standing water (2, 3, 4).
YFV can be inactivated by heat treatment at 50–60°C (104–122°F) for 30 minutes, by UV light, and by gamma radiation; it also is susceptible to low pH. A variety of disinfectants are effective against YFV, including 2% glutaraldehyde, 3–8% formaldehyde, 2–3% hydrogen peroxide, 70% ethanol, 500–5,000 ppm available chlorine, 1% iodine, and phenol iodophors (2, 3).
Key Points
Yellow fever is a mosquito-borne viral disease endemic in Africa and South America.
Neotropical primates (particularly howler monkeys) are at highest risk; African primates are less likely to become ill when infected.
Vaccines against yellow fever are available for humans and have been shown to be protective in nonhuman primates.
For More Information
Flavivirus (Causing Yellow Fever) (Infection With). Technical Disease Card. WOAH.
Yellow Fever Virus: Infectious Substances Pathogen Safety Data Sheet. Public Health Agency Canada.
Nederlof RA, Virgilio T, Hendrickus JJS, et al. Yellow fever in non-human primates: a veterinary guide from a One Health perspective, 2025. Vet Sci. 2026;12(4):339.
Also see pet owner content regarding yellow fever.
References
CDC. Yellow fever. April 23, 2025. Accessed October 10, 2026. https://www.cdc.gov/yellow-book/hcp/travel-associated-infections-diseases/yellow-fever.html
WOAH. Flavivirus (causing yellow fever) (infection with). https://www.woah.org/en/document/flavivirus-causing-yellow-fever-infection-with
Public Health Agency of Canada. Yellow fever virus: infectious substances pathogen safety data sheet. Modified February 19, 2026. Accessed October 10, 2026. https://www.canada.ca/en/public-health/services/laboratory-biosafety-biosecurity/pathogen-safety-data-sheets-risk-assessment/yellow-fever-virus.html
Nederlof RA, Virgilio T, Hendrickus JJS, et al. Yellow fever in non-human primates: a veterinary guide from a One Health perspective, 2025. Vet Sci. 2026;12(4):339. doi:10.3390/vetsci12040339
WHO. Yellow fever. October 20, 2025. Accessed October 10, 2026. https://www.who.int/news-room/fact-sheets/detail/yellow-fever



